跳转至内容
Merck
CN

420099

Millipore

JAK抑制剂I

≥98% (HPLC), solid, JAK inhibitor, Calbiochem®

别名:

Janus蛋白酪氨酸激酶(JAK)抑制剂I, 2-（1，1-二甲基乙基）-9-氟-3，6-二氢-7H-苯并[h]-咪唑[4，5-f]异喹啉-7-酮，吡啶酮6，P6，DBI，JAK1抑制剂I，JAK2抑制剂I，JAK3抑制剂X

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C18H16FN3O
化学文摘社编号:
457081-03-7
分子量:
309.34
MDL编号:
MFCD17019334
UNSPSC代码:
12352200
NACRES:
NA.77

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

JAK抑制剂I, JAK Inhibitor I, CAS 457081-03-7, is a potent, reversible, cell-permeable, and ATP-competitive inhibitor of JAK 1 (IC50 = 15 nM), JAK2 (IC50 = 1 nM), JAK3 (Ki = 5 nM) and Tyk2 (IC50 = 1 nM).

质量水平

100

方案

≥98% (HPLC)

表单

solid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
protect from light

颜色

off-white to light brown

溶解性

DMSO: 5 mg/mL

运输

ambient

储存温度

−20°C

SMILES字符串

Fc1cc2c(c3[nH]c(nc3c4c2c(ncc4)O)C(C)(C)C)cc1

InChI

1S/C18H16FN3O/c1-18(2,3)17-21-14-10-5-4-9(19)8-12(10)13-11(15(14)22-17)6-7-20-16(13)23/h4-8H,1-3H3,(H,20,23)(H,21,22)

InChI key

VNDWQCSOSCCWIP-UHFFFAOYSA-N

相关类别

一般描述

一种有效、可逆、细胞可渗透和ATP竞争性的Janus蛋白酪氨酸激酶（JAKs）抑制剂。显示对JAK1（对于鼠JAK1，IC50=15 nM）、JAK2（IC50=1 nM）、JAK3（Ki=5 nM）和Tyk2（IC50=1 nM）的有效抑制活性。在高得多的浓度下抑制其他激酶。显示抑制IL2和IL4依赖性的CTLL细胞增殖，并阻断STAT5的磷酸化；并且与AG 490（目录编号658401）不同，进一步诱导表达活化的JAKs和STAT3的多发性骨髓瘤细胞的生长抑制。也可获得10 mM（500 µg/162 µl）JAK抑制剂I的DMSO溶液（目录号420097）。
一种有效、细胞可渗透、可逆和ATP竞争性的Janus蛋白酪氨酸激酶（JAKs）抑制剂。显示对JAK1（对于鼠JAK1，IC50=15 nM）、JAK2（IC50=1 nM）、JAK3（Ki=5 nM）和Tyk2（IC50=1 nM）的有效抑制活性。在高得多的浓度下抑制其他激酶。显示抑制IL2和IL4依赖性的CTLL细胞增殖，并阻断STAT5的磷酸化；并且与AG 490（目录编号658401）不同，进一步诱导表达活化的JAKs和STAT3的多发性骨髓瘤细胞的生长抑制。

生化/生理作用

主要靶标
鼠JAK1
产物与ATP竞争。
可逆性：是
细胞可渗透性：是
靶标IC50：15 nM，针对鼠JAK1；1 nM，针对JAK2；1 nM，针对Tyk2
靶标Ki：5 nM，针对JAK3

包装

用惰性气体包装

制备说明

复溶后，等分并冷冻（-20°C）。储备溶液在-20°C下可稳定保存至多3个月。

其他说明

Pedranzini, L., et al. 2006.Cancer Res.66, 9714.
Lucet, I.S., et al. 2005.Blood107, 176.
Thompson, J.E., et al. 2002.Bioorg.Med. Chem. Lett.12, 1219.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

毒性：标准处理（A）

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Pratap Karki et al.
Cellular signalling, 53, 246-255 (2018-10-20)
Exposure to particulate matter (PM) associated with air pollution remains a major public health concern, as it has been linked to significant increase in cardiopulmonary morbidity and mortality. Lung endothelial cell (EC) dysfunction is one of the hallmarks of cardiovascular
Dongbum Kim et al.
BMB reports, 54(8), 425-430 (2021-04-10)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces coronavirus disease 2019 (COVID-19) and may increase the risk of adverse outcomes in lung cancer patients. In this study, we investigated the expression and function of mucin 1 (MUC1) after SARS-CoV-2 infection
Fuyuko Takata et al.
Journal of cellular biochemistry, 119(11), 9055-9063 (2018-08-05)
Oncostatin M (OSM) is a member of the interleukin (IL)-6 family cytokines. We previously demonstrated that OSM induces blood-brain barrier (BBB) impairment. However, functional characterization of IL-6 family cytokines in BBB regulation and the cytokine-related intracellular signaling pathway remain unclear.
Hannah M Burgess et al.
Genes & development, 35(13-14), 1005-1019 (2021-06-26)
N6-methyladenosine (m6A) is an abundant internal RNA modification, influencing transcript fate and function in uninfected and virus-infected cells. Installation of m6A by the nuclear RNA methyltransferase METTL3 occurs cotranscriptionally; however, the genomes of some cytoplasmic RNA viruses are also m6A-modified.
Ian C Henrich et al.
Cancer research, 81(8), 2171-2183 (2021-02-10)
Ewing sarcoma is the second most common pediatric bone cancer, with a 5-year survival rate for metastatic disease of only 20%. Recent work indicates that survival is strongly correlated with high levels of tumor-infiltrating lymphocytes (TIL), whose abundance is associated
查看所有相关文献

相关内容

An Introduction to Inhibitors and Their Biological Applications - 1st Edition

An Introduction to Inhibitors and Their Biological Applications

Pathways and Biomarkers of JAK/STAT Signaling

Pathways and Biomarkers of JAK/STAT Signaling

JAK/STAT Signaling Research Focus

The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway plays an important role in cell proliferation, cell differentiation, cell migration, and cell death. It is the principal signaling mechanism for a variety of cytokines and growth factors. Constitutive activation or dysregulation of JAK/STAT signaling can result in inflammatory disease, erythrocytosis, gigantism, and leukemia.

Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持